研究者情報 | |
ヤマダ ショウヘイ
YAMADA SHOHEI 山田将平 所属 医学部医学科 腎臓・高血圧内科 職種 助教 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Effect of GLP-1 Receptor Agonist, Liraglutide, on Muscle in Spontaneously Diabetic Torii Fatty Rats |
掲載誌名 | 正式名:Molecular and Cellular Endocrinology 略 称:Mol Cell Endocrinol |
掲載区分 | 国外 |
出版社名 | ELSEVIER |
巻・号・頁 | 1(539),111472頁 |
著者・共著者 | Yamada S, Ogura Y, Inoue K, Tanabe J, Sugaya T, Ohata K, Nagai Y, Natsuki Y, Hoshino S, Watanabe S, Ichikawa D, Kimura K, Shibagaki Y, Kamijo-Ikemori A |
担当区分 | 筆頭著者 |
発行年月 | 2022/01 |
概要 | This study investigated the effect of liraglutide, a glucagon-like peptide-1 receptor agonist, on skeletal muscles in rats with type 2 diabetes. Male SDT fatty rats (8-week-old) were provided liraglutide, or insulin-hydralazine for 8 weeks; control SDT fatty rats and SD rats were administered a vehicle. At 16 weeks of age, muscle strength of limbs was significantly lower in all SDT fatty rats compared to SD rats. While cross-sectional areas of type IIb muscle fibers in extensor digitorum longus muscle were significantly lower in SDT fatty rats than in SD rats, those of type I muscle fibers in soleus were similar in all rats. In the soleus of SDT fatty rats, liraglutide led to greater citrate synthase activity and cytochrome c oxidase subunit 5B protein expression, independently of blood glucose and blood pressure levels. Liraglutide may contribute to preservation of mitochondrial content on soleus muscle in type 2 diabetes. |
DOI | 10.1016/j.mce.2021.111472 |